Background/Aims: Interleukin-1 (IL-1) is known to be involved in cartilage degeneration following joint injury or due to osteoarthritis. In the present study, we explored the effects of miR-150 on IL-1-stimulated human chondrogenic cells ATDC5. Methods: ATDC5 cells were transfected with the mimic, inhibitor or negative controls specific for miR-150, and subsequently treated by IL-1. CCK8 assay, PI and FITC-conjugated Annexin V double-staining, Western blot, qRT-PCR and ELISA assay were performed to determine the changes of cell viability, apoptosis, and the release of pro-inflammatory cytokines. Targeting relationship between miR-150 and KLF2 was detected by dual luciferase activity assay. Results: IL-1 reduced cell viability, induced apoptosis, and enhanced the expression and release of pro-inflammatory cytokines (IL-6, IL-8 and TNF-α) in ATDC5 cells. IL-1 also increased the expression of miR-150. Suppression of miR-150 alleviated IL-1-induced cell damage in ATDC5 cells, while overexpression of miR-150 resulted in an opposite impact. KLF2 was negatively regulated by miR-150, and it was proved as a target gene of miR-150. KLF2 overexpression exhibited protective actions in IL-1-injured ATDC5 cells, even if miR-150 was suppressed in cell. Moreover, IL-1-induced activation of NF-kB and Notch pathways was alleviated by KLF2 overexpression. Conclusions: Suppression of miR-150 led to up-regulation of KLF2, which in turn protected ATDC5 cells against IL-1-induced injury.
Introduction
Osteoarthritis (OA) is a common form of degenerative joint disease which is accompanied by pain and joint dysfunction. Currently, available treatments for OA are restricted to relieve symptoms which cannot achieve the goal of preventing or curing OA. Patients with OA take paracetamol, non-steroidal anti-inflammatory drugs (NSAIDs), COX-2 inhibitors or injection of glucocorticoid and hyaluronic acid, but there are several side-effects. For example, naproxen, one kind of NSAIDs, is associated with an elevated risk of gastrointestinal tract complications [1] . Celecoxib, a selective inhibitor of COX-2, has no significantly adverse gastrointestinal effects, but higher risk of myocardial infarction [2] . Thus, novelly, safely, and effectively therapeutic strategies are required to be developed for the treatment of OA.
OA has been identified as a non-inflammatory arthritis. However, the dichotomy between inflammatory and degenerative arthritis is still not clear with the recognition of a plethora of ongoing immune processes within the OA joint and synovium. Anti-anabolic and pro-catabolic activities of inflammatory cytokines, particularly interleukin-1 (IL-1) are known to be involved in cartilage degeneration following joint injury or due to OA. IL-1 production is triggered in injured and degenerated joints, which in turn is known to induce pro-inflammatory pathways. Nowadays, IL-1 has been widely used for establishing the in vitro model of OA [3, 4] . microRNAs (miRNAs) are single-stranded RNA molecules that are widespread presented in eukaryotes, containing about 17 to 25 nucleotides. During OA, many miRNAs are expressed abnormally, and thus miRNAs present in human plasma and synovial fluid have been considered as promising biomarkers for OA [5] . For instance, the expressions of miR-483, miR-22, and miR-377 were elevated, and miR-140, miR-29a and miR-25 were downregulated in OA chondrocytes [6] . Besides, a growing number of miRNAs have been reported to be implicated in the development of OA. Hwang and his colleagues have demonstrated that miR-365 prevented IL-1-induced extracellular matrix loss by targeting HIF-2α [7] . Wu et al., reported that suppression of miR-1246 significantly reduced LPS-induced inflammatory injury in chondrogenic cells [8] .
miR-150 is one of the most popular and widely studied miRNAs. It has been reported to be low expressed in osteosarcoma tissues and cell lines, and acted as an anti-cancer gene [9] . Besides, it is a key modulator involved in orchestrating inflammation [10] . However, the role of miR-150 in OA has not been revealed yet. This study was designed to investigate the effect of miR-150 dysregulation on IL-1-induced chondrocyte injury in vitro. In addition, the relationship between miR-150 and KLF2 was explored to reveal the possibly underling mechanisms of miR-150's action.
Materials and Methods

Cell culture and stimulation
The human chondrogenic ATDC5 cells (ECACC, Porton Down, Wiltshire, UK) were cultured in DMEM/ F12 medium (Sigma-Aldrich, St. Louis, MO) supplemented with 5% FBS (Gibco, Grand Island, NY), 100 U/ mL penicillin (Sigma-Aldrich), and 100 μg/mL streptomycin (Sigma-Aldrich) in a humidified incubator with 95% air and 5% CO 2 at 37°C. The cells were routinely cultured in in 6-well plates (Corning, New York, NY) with a density of 6 × 10 4 /well. The recombinant IL-1β with purity greater than 98% (HPLC) was purchased from Sigma-Aldrich. Cells were treated by 1 ng/mL IL-1β for 12 h, as previously described [11] .
Cell transfection
The miR-150 mimic, miR-150 inhibitor and their correspondingly controls (Scramble and anti-NC) were synthesized by GenePharma Co (Shanghai, China).
The full-length wide-type KLF2 sequences were inserted into the pEX-2 plasmid (GenePharma). An empty pEX-2 plasmid was transfected as a negative control. siRNA specific for KLF2 was constructed into U6/Neo plasmid (GenePharma). An empty U6/Neo plasmid with non-targeting sequences was transfected as a negative control. Cell transfections were conducted using Lipofectamine 3000 reagent (Invitrogen) under non-serum condition. ) in 96-well plate were treated by IL-1 for 12 h. After another 24 h of incubation at fresh culture medium, cell viability was assessed by using CCK-8 (Dojindo Molecular Technologies, Kyushu, Japan). Briefly, the culture medium was removed, and the cells were washed twice with phosphate buffer saline (PBS). 10 μL CCK-8 solution was added, and the plates were incubated for 1 h at 37°C. The absorbance was measured at 450 nm using a Microplate Reader (Bio-Rad, Hercules, CA).
Apoptosis assay
The ATDC5 cells (5 × 10 5 ) in 6-well plates were undergone transfection and IL-1 treatment, after which cell apoptosis was analyzed using Annexin V-FITC/PI apoptosis detection kit (Invitrogen, Carlsbad, CA). Briefly, 1 × 10 5 cells from each sample were washed twice with PBS, and stained with Annexin V-FITC and PI according to the manufacturer's protocol in the presence of 50 μg/mL RNase A (Sigma-Aldrich). Apoptotic cells were distinguished by the FACS can (Beckman Coulter, Fullerton, CA). Data were quantified by using FlowJo software (Tree Star Inc. Ashland, OR).
qRT-PCR
qRT-PCR was performed to detect the mRNA levels of IL-6, IL-8, TNF-α, KLF2, and the RNA levels of miR-150 in ATDC5 cells after transfection and IL-1 treatment. Total RNAs in ATDC5 cells were extracted using RNA pure Rapid Extraction Kit (Bioteke Corporation, Beijing, China). cDNA was transcribed using SuperScript TM IV First-Strand Synthesis System (Invitrogen). SYBRTM Green PCR Master Mix (Applied Biosystems, Foster City, CA) and mirVana TM qRT-PCR miRNA Detection kit (Invitrogen) were respectively used for detection of mRNA and miRNA expressions. GAPDH and U6 were used for internal controls. Data were quantified using the 2 −△△CT method.
ELISA
The ATDC5 cells (5 × 10 4 ) in 24-well plates were undergone transfection and IL-1 treatment, after which culture supernatant was collected. The concentrations of IL-6, IL-8 and TNF-α in the culture supernatant were measured by ELISA kits (R&D Systems, Abingdon, UK) according to the manufacturers' protocol.
Dual luciferase activity assay
The 3'UTR target site was generated by PCR and the luciferase reporter constructs with the KLF2 3'UTR carrying a putative miR-150-binding site into pMiR-report vector were amplified by PCR. Cells were co-transfected with the reporter construct, control vector and miR-150 or scramble using Lipofectamine 3000 (Life Technologies, USA). Reporter assays were done using the dual-luciferase assay system (Promega) following to the manufacturer's information.
Western blot
Total protein in ATDC5 cells after relevant transfection and treatment were extracted using RIPA lysis buffer (Beyotime, Shanghai, China). The purity of proteins was quantified by the BCA™ Protein Assay Kit (Pierce, Appleton, WI). Western blot system was established using a Bio-Rad Bis-Tris Gel system (BioRad Laboratories, Hercules, CA). Proteins in equal concentration were electrophoresed in PAGE-SDS and transferred onto PDVF membranes (Millipore, Bedford, MA). After blocking in the 5% blocking buffer (Beyotime), the membranes were incubated with primary antibodies which were prepared in 5% blocking buffer at a dilution of 1:1, 000. After incubation with primary antibodies at 4°C overnight, the PDVF membranes were incubated with secondary antibody for 1 h at room temperature. Signals of the bands were captured using Bio-Rad ChemiDoc TM XRS system (Bio-Rad). The intensity of the bands was quantified using Image Lab™ Software (Bio-Rad).
Statistical analysis
Unless part of the data from Western blot analysis, all other data is presented as the mean ± SD. Statistics were analyzed by the one-way analysis of variance (ANOVA) in SPSS 19.0 statistical software (SPSS Inc., Chicago, IL). A p-value of lower than 0.05 was considered as a significant result. 
Results
IL-1 induces cell injury and release of pro-inflammatory cytokines in chondrocytes
A significant reduction of cell viability measured by CCK-8 assay was observed in ATDC5 cells treated with IL-1 as compared to the control cells (p < 0.05) (Fig. 1A) . Apoptosis measured by PI and FITC double-staining was significantly increased in cells treated with IL-1 compared to control cells (p < 0.001) (Fig. 1B) . The induced apoptosis by IL-1 was also confirmed by performing Western blot analysis. As shown in Fig. 1C , Bcl-2 was downregulated, Bax was up-regulated and caspase-3 and -9 were cleaved remarkably in cells treated with IL-1 as compared to the control cells. Moreover, cells treated with IL-1 showed increased mRNA expressions (Fig. 1D) and concentrations of IL-6, IL-8 and TNF-α (Fig. 1E,  F and G) .
IL-1 induces the expression of miR-150
Enhanced expression of miR-150 quantified by RT-PCR was observed in cells treated with IL-1 as compared to control cells (p < 0.01) (Fig. 2) .
Overexpression and suppression of miR-150
Significantly enhanced expression of miR-150 was observed in cells transfected with miR-150-mimic as compared to scramble cells (p < 0.01). Expression of miR-150 was suppressed in cells transfected with anti-miR-150 as compared to anti-NC (p < 0.01) (Fig. 3) . 
Overexpression of miR-150 aggravates IL-1-induced cell injury
A decreased viability was observed in cells transfected with miR-150-mimic compared to scramble cells (p < 0.05) (Fig. 4A) . Of contrast, an increased cell-viability was observed in cells transfected with anti-miR-150 compared to anti-NC (p < 0.05) (Fig. 4A) . Apoptosis was significantly increased in cells transfected with miR-150-mimic compared to scramble cells (p < 0.05) (Fig. 4B and C) . A significant decrease in apoptosis was observed in cells transfected with anti-miR-150 compared to anti-NC (p < 0.05) (Fig. 4B and C) . Also, enhanced expression and release of IL-6, IL-8 and TNF-α were observed in cells transfected with miR-150-mimic compared to scramble cells (p < 0.05), as observed by qRT-PCR and ELISA assay (Fig. 4D, E, F and G) . As expected, anti-miR-150 impacted the expression and release of IL-6, IL-8 and TNF-α resulted in completely apposite results.
MiR-150 negatively regulates KLF2, and KLF2 is a target of miR-150
A significant decrease of KLF2 expression was observed in cells transfected with miR-150-mimic compared to scramble cells (p < 0.05). On the contrary, an increased expression of KLF2 was observed in cells transfected with anti-miR-150 compared to anti-NC (p < 0.01) (Fig. 5A and B) . The dual luciferase assay demonstrated that KLF2 was a target of miR-150, as observed by significantly reduced luminescence in cells transfected with miR-150-mimic compared to scramble control cells (p < 0.05) (Fig. 5C) . 
Suppression of miR-150 reduces cell injury by overexpression of KLF2
A significant increase of KLF2 expression was observed in pEX-KLF2 transfected cells compared to pEX transfected cells (p < 0.01) (Fig. 6A and B) . Meanwhile, KLF2 expression was significantly suppressed by sh-KLF2 compared to sh-NC (p < 0.01) (Fig. 6A and B) . Of note, compared to the IL-1+anti-miR-150+shNC group, cell viability was reduced (p < 0.05, Fig. 6C ), apoptosis was enhanced (p < 0.01, Fig. 6D and E) , and the expression and release of pro-inflammatory cytokines were increased (p < 0.05, Fig. 6F , G, H and I) significantly in IL-1+anti-miR-150+sh-KLF2 group.
Overexpression of KLF2 reduces IL-1-induced cell injury
Cell viability was significantly increased in cells transfected with pEX-KLF2 compared to cells transfected with pEX (p < 0.05); meanwhile, a significant decrease of viability was observed in sh-KLF2 compared to sh-NC (p < 0.05) (Fig. 7A) . Similarly, a decrease in 
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Cellular Physiology and Biochemistry apoptosis was observed in cells transfected with pEX-KLF2 compared to cells transfected with pEX (p < 0.05), and apoptosis was significantly induced by sh-KLF2 compared to sh-NC (p < 0.05) (Fig. 7B and 7C ). Significantly decreased expression and release of IL-6, IL-8 and TNF-α were observed in cells transfected pEX-KLF2 (p < 0.05) when compared to pEX (Fig. 7D, E, F and G) . sh-KLF2 affected on the expression and release of IL-6, IL-8 and TNF-α resulted in apposite results.
Overexpression of KLF2 represses the activation of NF-kB and Notch pathways
IL-1 remarkably phosphorylated p65, and IκBα, and up-regulated Notch-1, Notch-2 and Notch-3 (Fig. 8) . The phosphorylation and up-regulation induced by IL-1 were attenuated by pEX-KLF2, while were accelerated by sh-KLF2 (Fig. 8) .
Discussion
OA is often associated with multiple risk factors, most notably age, joint trauma, altered biomechanics, and obesity [12, 13] . There are scientific reports suggest that pathologic changes related to OA share a common final pathway and subsequently operate to perpetuate joint destruction and eventual failure. It was reported that IL-1 was involved in the pathogenesis of OA, that it could significantly reduce chondrocytes proliferation, induced cell death, and accelerate inflammation [14, 15] . This was also confirmed in the current study, that IL-1 reduced ATDC5 cells viability, induced apoptosis and the increased the release of pro-inflammatory cytokines, like IL-6, IL-8 and TNF-α. These data indicated that apoptotic and inflammatory injury was significantly induced by IL-1 in ATDC5 cells.
We also showed that miR-150 was highly expressed in response to IL-1 treatment. More importantly, miR-150 suppression attenuated IL-1-induced injury in ATDC5 cells, as evidenced by the increased viability, the reduced apoptosis and the repressed release of proinflammatory cytokines. The functions of miR-150 in cell survival have been widely studied previously, but the exact role of miR-150 was confusing. Several studies suggested that miR- [18] . Our findings were consistence with the study of Qin, suggested the protective effects of miR-150 suppression on IL-1-injured ATDC5 cells. This contradiction may be caused by different cell types and stimulations. KLFs are a member of a multigene family of transcriptional factors having a three-Cys2-His2-zinc-finger domain [19, 20] . Studies demonstrate a key role for the KLFs in various processes of cell growth and differentiation. KLF2 is a zinc finger-containing transcription factor, and has been identified as a modulator of the pro-inflammatory response [21] . KLF2 has been shown to mediate anti-inflammatory effects of atheroprotective flow by inhibition of pro-inflammatory transcription factor ATF2 [22] . Das et al. reported that THP-1 cells overexpressing KLF2 showed reduced LPS-mediated induction of pro-inflammatory cytokines and chemokines [23] . In the present study, we found that KLF2 was a target gene of miR-150. Besides, the protective actions of miR-150 suppression on IL-1-induced cell injury were partially eliminated by KLF2 silencing. Our data indicated that miR-150 suppression alleviated inflammatory injury induced by IL-1 possibly via targeting KLF2 in ATDC5 cells.
The pathogenesis of OA involves multiple signaling pathways, among which NF-kB and Notch signaling pathways play significant roles in cartilage damage [24] . Following IL-1 treatment, transcriptional activity of NF-kB is enhanced [25] , which in turn regulates genes involved in immune response, inflammation and cell survival [26, 27] . Notch signaling determines cell fate via regulation of differentiation and apoptosis [28] . In a murine surgical model, inhibition of Notch signaling in chondrocytes suppresses OA development [29] . Thus, core factors in NF-kB and Notch signaling pathways have been considered as potential therapeutic OA targets [30] . Herein, we showed that IL-1-induced activation of NF-kB and Notch pathways was alleviated by KLF2 overexpression, indicating KLF2 protected ATDC5 via modulation of these two pathways.
To conclude, our findings in this study demonstrated a protective function of miR-150 suppression on IL-1-injured ATDC5 cells. The protective actions might be released by targeting KLF2 and modulation of NF-kB and Notch pathways. This study provides a novel insight into the role of miR-150 in IL-1 induced injury in OA.
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